{"id": "1371507753248821251", "creation": 1615827904.0, "user_id": "1222445686114934786", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}}, "text": "Ramping up production to supply #covid #vaccine is a stance that most #biopharma companies are taking. Capacity is a key element to consider &amp; understanding risks is also crucial. \n\nFind out more via @PharmaReview article (pg. 38 -41): https://t.co/12TPmqmj3B\n#pharma #covid19 https://t.co/C4SPkIRjcO", "first_save": 1634559108.199414, "hashtags": ["#COVID", "#VACCINE", "#BIOPHARMA", "#PHARMA", "#COVID19"]}